Key result
Emergency biliary-pancreatic surgical and high-risk endoscopic procedures were safely performed in 11 consecutive patients on uninterrupted dual antiplatelet therapy with no evidence of bleeding.
Why the study?
Does emergency biliary-pancreatic surgery or endoscopic retrograde cholangiography cause bleeding in patients on dual antiplatelet therapy?
Observational (n=11)
No
Does emergency biliary-pancreatic surgery or endoscopic retrograde cholangiography cause bleeding in patients on dual antiplatelet therapy?
Emergency biliary-pancreatic surgical and endoscopic procedures may be safely performed in patients on dual antiplatelet therapy without significant bleeding risk.
BACKGROUND/AIMS: Dual antiplatelet therapy has to be used for at least 1 month after placement of bare metal coronary stents and for a minimum of 1 year after placement of drug eluting stents. Because of the higher risk of bleeding, guidelines strongly recommend to delay elective surgery until dual antiplatelet therapy is ended. However, no data are available regarding the bleeding risk in patients on combined aspirin/clopidogrel therapy undergoing surgical or high-risk endoscopic procedures. METHODS: We retrospectively analyzed the medical reports of patients on dual antiplatelet therapy, the patients who had to undergo emergency biliary-pancreatic surgery or endoscopic retrograde cholangiography with endoscopic sphincterotomy while in our unit between January 2009 and July 2012. RESULTS: In our series, biliary-pancreatic surgical and endoscopic procedures were safely performed in 11 consecutive patients on dual antiplatelet therapy with no evidence of bleeding. CONCLUSIONS: In emergency, surgical and high risk endoscopic procedures may be performed in patients on dual antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
Samie et al. (2013) conducted an observational in Biliary-pancreatic diseases requiring emergency surgery or endoscopy in patients on dual antiplatelet therapy (n=11). Uninterrupted dual antiplatelet therapy during biliary-pancreatic procedures was evaluated on Perioperative or postsphincterotomy bleeding. Emergency biliary-pancreatic surgical and high-risk endoscopic procedures were safely performed in 11 consecutive patients on uninterrupted dual antiplatelet therapy with no evidence of bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: